Annual Total Liabilities
$8.56 M
-$22.38 M-72.34%
01 July 2024
Summary:
BriaCell Therapeutics annual total liabilities is currently $8.56 million, with the most recent change of -$22.38 million (-72.34%) on 01 July 2024. During the last 3 years, it has fallen by -$21.81 million (-71.83%). BCTX annual total liabilities is now -73.46% below its all-time high of $32.25 million, reached on 31 July 2022.BCTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$8.56 M
-$3.88 M-31.19%
01 July 2024
Summary:
BriaCell Therapeutics quarterly total liabilities is currently $8.56 million, with the most recent change of -$3.88 million (-31.19%) on 01 July 2024. Over the past year, it has dropped by -$7.55 million (-46.86%). BCTX quarterly total liabilities is now -75.97% below its all-time high of $35.61 million, reached on 30 April 2023.BCTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.3% | -46.9% |
| 3 y3 years | -71.8% | +1019.2% |
| 5 y5 years | +655.1% | +562.0% |
BCTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.5% | at low | -76.0% | +1227.3% |
| 5 y | 5 years | -73.5% | +655.1% | -76.0% | +1227.3% |
| alltime | all time | -73.5% | >+9999.0% | -76.0% | >+9999.0% |
BriaCell Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $8.56 M(-72.3%) | $8.56 M(-31.2%) |
| Apr 2024 | - | $12.44 M(-39.5%) |
| Jan 2024 | - | $20.55 M(+27.6%) |
| Oct 2023 | - | $16.10 M(-48.0%) |
| July 2023 | $30.94 M(-4.1%) | $30.94 M(-13.1%) |
| Apr 2023 | - | $35.61 M(+0.5%) |
| Jan 2023 | - | $35.44 M(+26.1%) |
| Oct 2022 | - | $28.12 M(-12.8%) |
| July 2022 | $32.25 M(+6.2%) | $32.25 M(+4902.0%) |
| Apr 2022 | - | $644.70 K(-24.5%) |
| Jan 2022 | - | $853.60 K(+11.6%) |
| Oct 2021 | - | $764.60 K(-97.5%) |
| July 2021 | $30.37 M(+637.2%) | $30.37 M(+320.1%) |
| Apr 2021 | - | $7.23 M(+76.8%) |
| Jan 2021 | - | $4.09 M(+7.0%) |
| Oct 2020 | - | $3.82 M(-7.2%) |
| July 2020 | $4.12 M(+263.5%) | $4.12 M(+28.9%) |
| Apr 2020 | - | $3.20 M(+16.6%) |
| Jan 2020 | - | $2.74 M(+112.0%) |
| Oct 2019 | - | $1.29 M(+14.1%) |
| July 2019 | $1.13 M(-15.4%) | $1.13 M(+104.1%) |
| Apr 2019 | - | $555.40 K(-64.0%) |
| Jan 2019 | - | $1.54 M(+47.6%) |
| Oct 2018 | - | $1.04 M(-22.0%) |
| July 2018 | $1.34 M(+51.2%) | $1.34 M(-1.5%) |
| Apr 2018 | - | $1.36 M(+315.9%) |
| Jan 2018 | - | $327.10 K(-0.7%) |
| Oct 2017 | - | $329.30 K(-62.8%) |
| July 2017 | $885.90 K(+1722.8%) | $885.90 K(+6319.6%) |
| Apr 2017 | - | $13.80 K(+84.0%) |
| Jan 2017 | - | $7500.00(-77.2%) |
| Oct 2016 | - | $32.90 K(-32.3%) |
| July 2016 | $48.60 K(-58.5%) | $48.60 K(-37.1%) |
| Apr 2016 | - | $77.30 K(-4.3%) |
| Jan 2016 | - | $80.80 K(-23.2%) |
| Oct 2015 | - | $105.20 K(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2015 | $117.20 K(+368.8%) | $117.20 K(-3.6%) |
| Apr 2015 | - | $121.60 K(+2.7%) |
| Jan 2015 | - | $118.40 K(-94.3%) |
| Oct 2014 | - | $2.09 M(+8240.8%) |
| July 2014 | $25.00 K(-66.4%) | $25.00 K(-68.5%) |
| Apr 2014 | - | $79.40 K(+0.3%) |
| Jan 2014 | - | $79.20 K(+7.0%) |
| Oct 2013 | - | $74.00 K(-0.7%) |
| July 2013 | $74.50 K(-73.8%) | $74.50 K(+106.9%) |
| Apr 2013 | - | $36.00 K(+25.4%) |
| Jan 2013 | - | $28.70 K(-75.3%) |
| Oct 2012 | - | $116.00 K(-59.1%) |
| July 2012 | $283.90 K(-60.4%) | $283.90 K(+236.0%) |
| Apr 2012 | - | $84.50 K(+134.1%) |
| Jan 2012 | - | $36.10 K(-89.9%) |
| Oct 2011 | - | $357.20 K(-50.2%) |
| July 2011 | $716.70 K(+2354.5%) | $716.70 K(+863.3%) |
| Apr 2011 | - | $74.40 K(-12.9%) |
| Jan 2011 | - | $85.40 K(-6.3%) |
| Oct 2010 | - | $91.10 K(+212.0%) |
| July 2010 | $29.20 K(-54.5%) | $29.20 K(-27.7%) |
| Apr 2010 | - | $40.40 K(+329.8%) |
| Jan 2010 | - | $9400.00(-66.8%) |
| Oct 2009 | - | $28.30 K(-55.9%) |
| July 2009 | $64.20 K(+311.5%) | $64.20 K(+1046.4%) |
| Apr 2009 | - | $5600.00(-50.9%) |
| Jan 2009 | - | $11.40 K(+293.1%) |
| Oct 2008 | - | $2900.00(-81.4%) |
| July 2008 | $15.60 K(+62.5%) | $15.60 K(+437.9%) |
| Apr 2008 | - | $2900.00(-39.6%) |
| Jan 2008 | - | $4800.00(-63.4%) |
| Oct 2007 | - | $13.10 K(+36.5%) |
| July 2007 | $9600.00(-41.8%) | $9600.00(+380.0%) |
| Apr 2007 | - | $2000.00(+566.7%) |
| Jan 2007 | - | $300.00(-97.2%) |
| Oct 2006 | - | $10.90 K |
| July 2006 | $16.50 K | - |
FAQ
- What is BriaCell Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual total liabilities year-on-year change?
- What is BriaCell Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly total liabilities year-on-year change?
What is BriaCell Therapeutics annual total liabilities?
The current annual total liabilities of BCTX is $8.56 M
What is the all time high annual total liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual total liabilities is $32.25 M
What is BriaCell Therapeutics annual total liabilities year-on-year change?
Over the past year, BCTX annual total liabilities has changed by -$22.38 M (-72.34%)
What is BriaCell Therapeutics quarterly total liabilities?
The current quarterly total liabilities of BCTX is $8.56 M
What is the all time high quarterly total liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly total liabilities is $35.61 M
What is BriaCell Therapeutics quarterly total liabilities year-on-year change?
Over the past year, BCTX quarterly total liabilities has changed by -$7.55 M (-46.86%)